Smith Group Asset Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,060	Closed	-$39K	–	472
2015 Q3	$39K	Buy	4,060 +530	+15%	+$5.09K	﹤0.01%	292
2015 Q2	$36K	Buy	+3,530	New	+$36K	﹤0.01%	290